Predicting pancreatic cancer outcomes using imaging and blood test data

Researchers want to understand whether combining information from imaging scans, blood tests, and tissue reports can help predict how pancreatic cancer will progress in individual patients. This is an observational study, meaning you won't receive any new drugs or treatments — instead, researchers will use your existing medical records to develop a predictive model that could help doctors better understand outcomes for people with pancreatic cancer.

Doctors currently have limited tools to predict which pancreatic cancer patients will do well after surgery and which are at higher risk for recurrence. By combining multiple types of medical data, this model could help personalize care and improve decision-making for future patients.